Tasly: As of the first quarter, the company's drug sales revenue in the field of liver disease treatment increased by 33%, and related drugs are currently mainly sold in China Teller Report Teller Report

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

002913 300713 Aoshikang Technology Shenzhenrease Technology Tasly Pharmaceutica Group Medicine Children Athletics, Track, Field

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Tasly: As of the first quarter, the company's drug sales revenue in the field of liver disease treatment increased by 33%, and related drugs are currently mainly sold in China Teller Report Teller Report